Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)

Clinical trial NCT01346865 · TERMINATED

Trial details

NCT number: NCT01346865
Sponsor: Seung-Jung Park
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2011-05-01
Primary completion: 2015-02-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.